Treatable glomerular hyperfiltration in patients with active acromegaly.
暂无分享,去创建一个
K. Arita | K. Takano | R. Hanaya | Yasuyuki Kinoshita | C. Koriyama | Y. Nishio | M. Habu | Shingo Fujio | Manoj Bohara | H. Arimura | H. Hirano
[1] Ji-Eun Kim,et al. Clinical Usefulness of Serum Cystatin C as a Marker of Renal Function , 2014, Diabetes & metabolism journal.
[2] R. Bernays,et al. Impact of Growth Hormone on Cystatin C , 2013, Nephron Extra.
[3] G. Stalla,et al. Somatostatin receptors: From signaling to clinical practice , 2013, Frontiers in Neuroendocrinology.
[4] A. Levin,et al. Practice Guideline , 2020, Encyclopedia of Behavioral Medicine.
[5] J. Sarnthein,et al. Soluble α-klotho: a novel serum biomarker for the activity of GH-producing pituitary adenomas. , 2013, European journal of endocrinology.
[6] K. Chihara,et al. Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. , 2012, Endocrine journal.
[7] D. Chauveau,et al. Impact of growth hormone hypersecretion on the adult human kidney. , 2011, Annales d'endocrinologie.
[8] M. D. De Martino,et al. The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. , 2010, European journal of endocrinology.
[9] Yasuhiko Tomino,et al. Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] J. Scholey,et al. Insights into the regulation of renal hemodynamic function in diabetic mellitus. , 2008, Current diabetes reviews.
[11] S. Melmed. Medical progress: Acromegaly. , 2006, The New England journal of medicine.
[12] F. Schaefer,et al. Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling , 2005, Pediatric Nephrology.
[13] A. Flyvbjerg,et al. The physiological and pathophysiological roles of the GH/IGF-axis in the kidney: lessons from experimental rodent models. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[14] S. Prahalada,et al. Morphological Changes in the Kidney of Dogs Chronically Exposed to Exogenous Growth Hormone , 2000, Toxicologic pathology.
[15] F. Casanueva,et al. Criteria for cure of acromegaly: a consensus statement. , 2000, The Journal of clinical endocrinology and metabolism.
[16] J. Floege,et al. Effects of rhGH and rhIGF-1 on renal growth and morphology. , 1993, Kidney international.
[17] L. Sjöström,et al. Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and I year after adenomectomy , 1993, European journal of clinical investigation.
[18] B. Tönshoff,et al. Growth hormone-induced glomerular hyperfiltration is dependent on vasodilating prostanoids. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] D. Layish,et al. Growth hormone and the kidney: a case presentation and review of the literature. , 1992, Journal of the American Society of Nephrology : JASN.
[20] R. Dullaart,et al. Effect of a somatostatin analogue, octreotide, on renal haemodynamics and albuminuria in acromegalic patients , 1992, European journal of clinical investigation.
[21] D. Haffner,et al. The acute effect of growth hormone on GFR is obliterated in chronic renal failure. , 1989, Clinical nephrology.
[22] M. Carey,et al. A simple method for assessment of glomerular size and its use in the study of kidneys in acromegaly and compensatory renal enlargement , 1989, The Journal of pathology.
[23] E. Froesch,et al. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Kopple,et al. The delayed effect of growth hormone on renal function in humans. , 1989, Kidney international.
[25] R. Palmiter,et al. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. , 1988, The American journal of pathology.
[26] T. Adrian,et al. Electrophysiological actions of somatostatin on the atrioventricular junction in sinus rhythm and reentry tachycardia. , 1986, British heart journal.
[27] B. Brenner. Nephron adaptation to renal injury or ablation. , 1985, The American journal of physiology.
[28] J. Polak,et al. Somatostatin in the human heart and comparison with guinea pig and rat heart. , 1985, British heart journal.
[29] J. Christiansen,et al. Kidney function and size in normal subjects before and during growth hormone administration for one week , 1981, European journal of clinical investigation.
[30] T. Falkheden,et al. RENAL FUNCTION AND KIDNEY SIZE FOLLOWING HYPOPHYSECTOMY IN MAN. , 1965, Acta endocrinologica.
[31] J. Corvilain,et al. Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man. , 1962, The Journal of clinical investigation.
[32] H. Gershberg,et al. Renal function studies and autopsy report in a patient with gigantism and acromegaly. , 1957, The Journal of clinical endocrinology and metabolism.
[33] R. Luft,et al. Glomerular filtration rate and renal plasma flow in acromegaly. , 1956, Acta endocrinologica.
[34] R. Luft,et al. The significance of the adenohypophysis, adrenal cortex and thyroid in renal function in man. , 1950, Acta endocrinologica.